| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2788210 | 33 | F | NC | 09/03/2024 |
RSV RSV |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
97N55 |
Exposure during pregnancy, Product use issue; Delivery, Exposure during pregnanc...
Exposure during pregnancy, Product use issue; Delivery, Exposure during pregnancy, Haemorrhage in pregnancy, Product use issue
More
|
This patient was 32 weeks and 5 days when she received the Arevxy RSV vaccine that is not currently ...
This patient was 32 weeks and 5 days when she received the Arevxy RSV vaccine that is not currently approved for use during pregnancy. She is currently 33 weeks and 6 days. Patient was made aware and plans to report to Pediatrician as well.
More
|
||||||
| 2828476 | M | ME | 02/26/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Atrial fibrillation, Cardiac failure congestive, Inappropriate schedule of produ...
Atrial fibrillation, Cardiac failure congestive, Inappropriate schedule of product administration
More
|
Congestive heart failure; atrial fibrillation; dose 1 administred on 21Feb2021; dose 2 administered ...
Congestive heart failure; atrial fibrillation; dose 1 administred on 21Feb2021; dose 2 administered on 04Mar2021 for COVID-19 vaccination; This is a solicited report received from a Consumer or other non HCP. Other Case identifier(s): 846809 (Novo Nordisk Pharmaceuticals Inc. Mfr. Report#), S 20210902206 (Novo Nordisk Pharmaceuticals Inc.), IN20250215380 (Novo Nordisk Pharmaceuticals Inc.). An adult male patient received BNT162b2 (BNT162B2), on 04Mar2021 as dose 2, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation; insulin degludec (TRESIBA FLEXTOUCH), first regimen since 2020) and second regimen (Lot number: PZFAE39, Expiration Date: 30Jun2026) at 25 iU, all subcutaneous for diabetes mellitus. The patient's relevant medical history included: "Diabetes Mellitus" (ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (dose 1, inrtamuscular), administration date: 21Feb2021, for COVID-19 immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 04Mar2021, outcome "unknown", described as "dose 1 administred on 21Feb2021; dose 2 administered on 04Mar2021 for COVID-19 vaccination"; CARDIAC FAILURE CONGESTIVE (hospitalization, medically significant) with onset 07Apr2021, outcome "not recovered", described as "Congestive heart failure"; ATRIAL FIBRILLATION (hospitalization, medically significant) with onset 07Apr2021, outcome "unknown". The patient was hospitalized for cardiac failure congestive, atrial fibrillation (start date: 07Apr2021). The action taken for insulin degludec was unknown. Therapeutic measures were taken as a result of cardiac failure congestive, atrial fibrillation. Clinical course: A consumer reported that on 18May2021, as treatment, the patient underwent pacemaker. On an unspecified date, as further treatment, the patient was hospitalized, underwent atrial fibrillation ablation, and was placed on a breathing machine due to complications of congestive heart failure during surgery. After the surgery, the patient went home on oxygen therapy. The reporter felt that the congestive heart failure and atrial fibrillation were related to therapy with Comirnaty. The reporter's causality for Tresiba FlexTouch U200 with the events congestive heart failure and atrial fibrillation was unlikely. The Company's causality for Tresiba FlexTouch U200 with the events congestive heart failure and atrial fibrillation was unlikely. Reporter Comment: Alternative etiology: The reporter felt that the congestive heart failure and atrial fibrillation were related to therapy with Comirnaty. Company comment: Cardiac failure congestive and atrial fibrillation are assessed as unlisted events according to (redacted) current reference safety information (CCDS) on Tresiba FlexTouch. Information on patient's relevant medical history of coronary disease or other cardiac disease, action taken to Tresiba, associated risk factors (immobilization. reduced cardiac output, surgery, trauma, malignant diseases, infections, dehydration, hypertensive episodes, previous thrombo-embolic events), results from clinical and laboratory investigations performed are not available for further medical assessment. However, the co-suspect, Comirnaty is considered as confounding factor in the case. Congestive cardiac failure could be secondary to atrial fibrillation in the case. Considering the pharmacological profile of the suspect drug and available information, congestive cardiac failure and atrial fibrillation are assessed to be unlikely related to Tresiba FlexTouch. This single case report is not considered to change the current knowledge of the safety profile of Tresiba Flex Touch. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Reporter's Comments: Alternative etiology: The reporter felt that the congestive heart failure and atrial fibrillation were related to therapy with Comirnaty.; Sender's Comments: The events cardiac failure congestive, and atrial fibrillation are conservatively assessed as related to the suspect drug BNT162B2 based on plausible temporal association but consider also possible contributory effects from medical history of the patient such as diabetes mellitus and/or concomitant medication of INSULIN DEGLUDEC. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
More
|
โ | ||||||
| 2828477 | F | 02/26/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Illness
Illness
|
She just got really sick from getting the Pfizer a couple of times; This is a spontaneous report rec...
She just got really sick from getting the Pfizer a couple of times; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): NOV25-00069 (Novavax). An adult female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "She just got really sick from getting the Pfizer a couple of times". Additional Information: Caller was asked if she was immunocompromised or previously vaccinated against COVID-19 and if she was over 65 years old. Caller added she just got really sick from getting the Pfizer a couple of times so she did not know if this was a better alternative in the future to get this vaccine, like the hepatitis A, B, they have the same type of you know, the flu shot. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
More
|
||||||||
| 2828484 | M | 02/26/2025 |
COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH |
SJ1614 SJ1614 |
Anxiety, Burning sensation, Cough, Dyskinesia, Electric shock sensation; Magneti...
Anxiety, Burning sensation, Cough, Dyskinesia, Electric shock sensation; Magnetic resonance imaging, Pain, Paralysis, Seizure, Stress
More
|
paralyzed from the waist down; my leg started thumping like rabbit from the cartoon the little rabbi...
paralyzed from the waist down; my leg started thumping like rabbit from the cartoon the little rabbit that goes really fast/ my leg convulsion thing; intensely hot like it was burning like on fire when the MRI started to go down his leg; a lot of stress; a lot of mental anguish; cough; pain; his left leg/ it is not exactly muscle spasm is more of an electric surge running on his leg; his leg is jerking; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID. A male patient received BNT162b2 (BNT162B2), on 07Feb2022 as dose 1, single (Lot number: SJ1614) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ELECTRIC SHOCK SENSATION (non-serious) with onset 2022, outcome "unknown", described as "his left leg/ it is not exactly muscle spasm is more of an electric surge running on his leg"; DYSKINESIA (non-serious) with onset 2022, outcome "unknown", described as "his leg is jerking"; PAIN (non-serious) with onset 2022, outcome "unknown"; PARALYSIS (medically significant), outcome "unknown", described as "paralyzed from the waist down"; SEIZURE (medically significant), outcome "unknown", described as "my leg started thumping like rabbit from the cartoon the little rabbit that goes really fast/ my leg convulsion thing"; BURNING SENSATION (non-serious), outcome "unknown", described as "intensely hot like it was burning like on fire when the MRI started to go down his leg"; STRESS (non-serious), outcome "unknown", described as "a lot of stress"; ANXIETY (non-serious), outcome "unknown", described as "a lot of mental anguish"; COUGH (non-serious), outcome "unknown". The patient underwent the following laboratory tests and procedures: Magnetic resonance imaging: Unknown results. Clinical details: He said he is in pain. He is trying to figure out he is having side effect. It is his left leg and with his left leg he is having it is not exactly muscle spasm is more of an electric surge running on his leg. It only happens at specific times which is making it even stranger to him. He has videos of it and it has happened on multiple occasions usually when trying to meditate or going to go inside himself be very calm and still, because he thinks bodies vibrate on or can vibrate on different through frequency energy and vibration when are trying to align this 3 trying to ascend into spirit his leg is like when he gets a tense unit, he assumes, so it's like putting the pads on legs and send electric surges to the leg so this is happening all by itself. He is not using electricity or anything like that on the leg , his leg is jerking and he has had this problem since 2022, and he is really trying to get to the bottom and the only thing he keeps coming back to is the Pfizer shot and he only got one shot and this was back on 07Feb2022, and he is trying to figure out why this is happening. He went to get an MRI during this and when he went to get it and went into the MRI because he did the research on this. When he got in the MRI his leg when intensely hot like it was burning like on fire when the MRI started to go down his leg. So due to the magnet in it and the low frequency that they emit his leg started thumping like rabbit from Name withheld the little rabbit that goes really fast so that's what his leg started doing when the MRI was going through his leg and on top started to burn like it is on fire. The only thing that he could think of was that he was unknowingly injected with nanotechnology and he knows Pfizer deals with nanobots (as reported). He has done his research and this is the only conclusion he has come to, and he can not figure it out cause it is causing him a lot of stress causing a lot of mental anguish. It is really starting to piss him of, and he does not know what else to do about it is there a possibility there could be nanobots on the vaccine. It has been like this the past 3 years he is trying to figure out what he can do. He is paralyzed from the waist down and he has never had this happen to him until he went to get the Pfizer shot, once he got this Pfizer shot this is when it started happening and then when he started doing research on it about the MRI and everything. When he got into his MRI machine his leg got fire hot his leg convulsion thing that was his conclusion with that. It is only happening in his left leg and it is not happening anywhere else in his body and he is pretty sure it would not just only be happening in his left leg. It was also reported that the patient is not using anything that could cause this, and leg is jerking since 2022. This is for Comirnaty Vaccine. For the bottom of the cough it keeps coming back to the Pfizer shot, the Comirnaty that he got on 07Feb2022. He is trying to figure out why this is happening. His leg starting going thumbing like rabbit from the cartoon.
More
|
||||||||
| 2828485 | 71 | F | GA | 02/26/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
255T2 |
Extra dose administered
Extra dose administered
|
Pt given Arexvy a 2nd time, previously administered 8/23/2023
Pt given Arexvy a 2nd time, previously administered 8/23/2023
|
||||||
| 2828486 | 64 | F | FL | 02/26/2025 |
COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH |
EN9581 ,EP7534 EN9581 ,EP7534 |
Arthralgia, Loss of personal independence in daily activities, Mobility decrease...
Arthralgia, Loss of personal independence in daily activities, Mobility decreased, Muscular weakness, Musculoskeletal disorder; Tenderness
More
|
unberabl;e pain shoulder . couldnt move my arm for month. sensetive to the lightest tpuch evoke shar...
unberabl;e pain shoulder . couldnt move my arm for month. sensetive to the lightest tpuch evoke sharp pain. my arm was as paraloized,stuck. couldnt move,couldnt use, couldnt dress, . i went to my doctor to get help. i was reffered to the physical therapy, 3 times a week. supreme pai in the therapy. chiropracot, needle treatment. till today my left arm is weak.
More
|
โ | |||||
| 2828487 | 71 | F | WI | 02/26/2025 |
RSV VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
ae435 7zm65 |
Infection; Infection
Infection; Infection
|
a customer come in claiming she got an infection in her left arm after she received two vaccinations...
a customer come in claiming she got an infection in her left arm after she received two vaccinations from our pharmacy on Wednesday, Feb 19 at approximately noon. On Saturday, Feb 22 she sought medical attention to an urgent care facility for the infection she claimed she had gotten. Today Feb 23rd at 2:50pm she came into the store and stated she wanted it to be reported and brought in the medical paperwork she received.
More
|
||||||
| 2828488 | 26 | M | UT | 02/26/2025 |
COVID19 COVID19 COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
GH9694 GH9694 GH9694 GH9694 GH9694 |
Abdominal distension, Aldolase increased, Aspartate aminotransferase increased, ...
Abdominal distension, Aldolase increased, Aspartate aminotransferase increased, Biopsy muscle abnormal, Blood creatine phosphokinase increased; Blood lactate dehydrogenase increased, Blood test abnormal, Chest pain, Discomfort, Fatigue; Gastrointestinal pain, Lactate pyruvate ratio abnormal, Magnetic resonance imaging abnormal, Migraine, Muscle fatigue; Myoglobin blood increased, Neuralgia, Oedema, Pain, Palpitations; Rhabdomyolysis
More
|
I was an active and healthy prior to this vaccine with minimal doctor?s visits per year except for r...
I was an active and healthy prior to this vaccine with minimal doctor?s visits per year except for recurrent sinuses infections. Before this vaccine, I had less than 5 doctors appointments for the year. After this 4th bivalent shot, I have had over 200 visits to clinic and emergency medicine. I suffer from migraines, fatigue, gi bloating and pain, muscle fatigue and soreness, migraine, and nerve pain. I also get one-sided unilateral pain and pressure that will go from head to toe and switch side to side. I also experienced heart palpitations and chest pain.
More
|
โ | โ | ||||
| 2828489 | 64 | F | WI | 02/26/2025 |
FLU3 |
SANOFI PASTEUR |
|
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
Patient came in for an influenza vaccine and had a caregiver that filled out the Vaccine Administrat...
Patient came in for an influenza vaccine and had a caregiver that filled out the Vaccine Administration Record form. In the Date of Birth section they wrote the correct DOB of 8/XX/60, but in the Age section they wrote 65. The high dose influenza vaccine was run through the system due to the error on the form. Patient was then administered the high dose flu shot. The DOB/age discrepancy was noted shortly after patient and caregiver left. Caregiver was contacted and made aware of the situation and what to monitor concerning potential side effects. Staff was educated on error prevention.
More
|
||||||
| 2828498 | 70 | M | NY | 02/26/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
JS3S4 |
Herpes zoster
Herpes zoster
|
At vaccination patient had said he had shingles history. Patient returned to pharmacy said he got sh...
At vaccination patient had said he had shingles history. Patient returned to pharmacy said he got shingles from the vaccine he received. Patient was presribed valacyclovir and gabapentin for treatment.
More
|
||||||
| 2828499 | 65 | F | OH | 02/26/2025 |
COVID19 COVID19 COVID19 COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
EN6204 EN6204 EN6204 EW0158 EW0158 EW0158 |
Abdominal X-ray, Allergy to metals, Blood test, Colonoscopy abnormal, Constipati...
Abdominal X-ray, Allergy to metals, Blood test, Colonoscopy abnormal, Constipation; Diarrhoea, Dizziness, Endoscopy abnormal, Gastrointestinal inflammation, Heart rate abnormal; Magnetic resonance imaging abdominal abnormal, Nerve injury, Postural orthostatic tachycardia syndrome, Stool analysis; Abdominal X-ray, Allergy to metals, Blood test, Colonoscopy abnormal, Constipation; Diarrhoea, Dizziness, Endoscopy abnormal, Gastrointestinal inflammation, Heart rate abnormal; Magnetic resonance imaging abdominal abnormal, Nerve injury, Postural orthostatic tachycardia syndrome, Stool analysis
More
|
Developed severe diarrhea that Imodium and prescription anti-diarrheal had no impact. I had multiple...
Developed severe diarrhea that Imodium and prescription anti-diarrheal had no impact. I had multiple tests that could not determine what caused it. I reacted as if all food had gluten in it. Even the low fodmap diet didn't help. In July 2022 I had an endoscopy and colonoscopy. I had inflammation thru whole digestive system. Diarrhea ended in Dec 2022 after taking Rabeprazole and severe constipation started. I also started having light-headedness and dizzy spells in June 2021. In May 2022 I was diagnosed with POTS. Since my Vagus nerve damaged in 2016, I could not feel my heart rate issues. I bought a smartwatch and found out that my heart rate varied from 30 bpm to low 200s.
More
|
||||||
| 2828500 | 61 | M | GA | 02/26/2025 |
RSV |
PFIZER\WYETH |
LH4511 |
Fatigue
Fatigue
|
Feeling tired after 2-3 hours of vaccine administration
Feeling tired after 2-3 hours of vaccine administration
|
||||||
| 2828501 | 73 | F | RI | 02/26/2025 |
TDAP TDAP |
SANOFI PASTEUR SANOFI PASTEUR |
U8252AA U8252AA |
Arthralgia, Feeling abnormal, Intervertebral disc space narrowing, Neck pain, Pa...
Arthralgia, Feeling abnormal, Intervertebral disc space narrowing, Neck pain, Pain; Pain in extremity, Spinal X-ray abnormal, Spinal osteoarthritis, X-ray limb
More
|
Patient presented 02/21/2025 for office visit and described the event. No report of the event was re...
Patient presented 02/21/2025 for office visit and described the event. No report of the event was reported to our clinic prior to this date. Patient reported: - Experienced pain in the left shoulder after receiving a vaccine on November 27, 2023. - Pain began the same day as the vaccine administration. - Pain intensifies with arm movement, particularly when raising the arm or doing hair. Pain located in shoulder (deltoid region), and feelings a "weird feeling" radiate down arm over lateral arm and forearm with certain movements - She notes that the pain sometimes starts radiates from the mid left side of her neck and radiates neck down the left arm.
More
|
||||||
| 2828502 | 71 | M | UT | 02/26/2025 |
COVID19 FLU3 |
PFIZER\BIONTECH SANOFI PASTEUR |
LM2215 U8515CA |
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
None reported, but this dose of Fluzone HD was second dose of the season, he received first dose 08/...
None reported, but this dose of Fluzone HD was second dose of the season, he received first dose 08/24/2024.
More
|
||||||
| 2828503 | 65 | F | UT | 02/26/2025 |
COVID19 FLU3 |
PFIZER\BIONTECH SANOFI PASTEUR |
LM2211 U8515CA |
Extra dose administered; Extra dose administered
Extra dose administered; Extra dose administered
|
None reported, Fluzone HD dose given 10/05/2024 was second dose of 2024-25 version, first dose of Fl...
None reported, Fluzone HD dose given 10/05/2024 was second dose of 2024-25 version, first dose of Flublok was given 08/24/2024.
More
|
||||||
| 2828504 | 65 | F | AL | 02/26/2025 |
COVID19 FLU3 |
MODERNA SANOFI PASTEUR |
8081561 ut84j4aa |
Acne, Pustule; Acne, Pustule
Acne, Pustule; Acne, Pustule
|
patient state about a week after injection a pimple came up and popped and pus came out. just has no...
patient state about a week after injection a pimple came up and popped and pus came out. just has not healed in the meantime. just reported to me on 2/26/25
More
|
||||||
| 2828505 | 67 | M | WA | 02/26/2025 |
COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
FF2588 FF2588 FF2588 |
Amnesia, Anxiety, Asthma, Condition aggravated, Confusional state; Dizziness, Dy...
Amnesia, Anxiety, Asthma, Condition aggravated, Confusional state; Dizziness, Dyspnoea, Inflammation, Insulin resistance, Tremor; Wheezing
More
|
Shortness of breath, wheezing, dizziness, anxiety, shaky , tremors, confusion, memory loss, increase...
Shortness of breath, wheezing, dizziness, anxiety, shaky , tremors, confusion, memory loss, increased insulin resistance, inflammation, frequent asthma attacks.
More
|
โ | |||||
| 2828506 | 11 | F | CA | 02/26/2025 |
VARCEL |
MERCK & CO. INC. |
Y007637 |
Vomiting
Vomiting
|
Vomiting 1 hour after 2x with no fever
Vomiting 1 hour after 2x with no fever
|
||||||
| 2828507 | 75 | F | CA | 02/26/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
245M94 |
Injection site erythema, Injection site pain
Injection site erythema, Injection site pain
|
Redness around vaccination injection site. Patient was complaining that injection site hurts on 2/25...
Redness around vaccination injection site. Patient was complaining that injection site hurts on 2/25/2025. Per personnel, arm is getting better on 2/26/2025. Ice was applied and arm was elevated.
More
|
||||||
| 2828508 | 65 | F | VA | 02/26/2025 |
UNK |
UNKNOWN MANUFACTURER |
|
Unevaluable event
Unevaluable event
|
ER
ER
|
||||||
| 2828509 | 70 | F | FL | 02/26/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
255T2 |
Areflexia, CSF protein increased, Immunoglobulin therapy, Muscular weakness, Par...
Areflexia, CSF protein increased, Immunoglobulin therapy, Muscular weakness, Paralysis
More
|
Patient experienced lower extremity weakness starting Tuesday 2/18/25 which progressed to full paral...
Patient experienced lower extremity weakness starting Tuesday 2/18/25 which progressed to full paralysis on Friday 2/21/25. Patient had no reflexes upon presentation at ER and underwent lumbar puncture. She received IGG with improvement in symptoms and no worsening or further paralysis.
More
|
โ | โ | ||||
| 2828510 | 62 | F | WA | 02/26/2025 |
COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH |
FF2588 FF2588 |
Arthritis, Asthenia, Chest discomfort, Dizziness, Dyspnoea; Wheezing
Arthritis, Asthenia, Chest discomfort, Dizziness, Dyspnoea; Wheezing
|
Shortness of breath, tightness in chest came in shortly after the dose of Pfizer vaccine. Weakness a...
Shortness of breath, tightness in chest came in shortly after the dose of Pfizer vaccine. Weakness and increased inflammation in joints, dizziness, wheezing are all symptoms I experienced since having the series of the Pfizer vaccine.
More
|
โ | |||||
| 2828511 | 30 | M | TX | 02/26/2025 |
COVID19 COVID19 COVID19 |
MODERNA MODERNA MODERNA |
028L20A 028L20A 028L20A |
Abdominal pain, Blood alkaline phosphatase increased, COVID-19, Computerised tom...
Abdominal pain, Blood alkaline phosphatase increased, COVID-19, Computerised tomogram abdomen normal, Malaise; Nausea, Primary biliary cholangitis, Scan with contrast normal, Smooth muscle antibody positive, Transaminases increased; Vomiting
More
|
The following events are before any COVID19 infection: first 48H after the vaccine administration, d...
The following events are before any COVID19 infection: first 48H after the vaccine administration, developed malaise, 72H after vaccine administration started with severe abdominal pain, nausea and vomiting, that prompted ED visit.
More
|
โ | |||||
| 2828512 | 66 | F | NV | 02/26/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
unknown unknown |
Appendicitis perforated, Blood test, Computerised tomogram, Intra-abdominal flui...
Appendicitis perforated, Blood test, Computerised tomogram, Intra-abdominal fluid collection, Magnetic resonance imaging; Pernicious anaemia, Tumour marker test
More
|
1. Pernicious Anemia onset 4 months after 1 Moderna dose mRNA Covid. Treatment has been B-12 injecti...
1. Pernicious Anemia onset 4 months after 1 Moderna dose mRNA Covid. Treatment has been B-12 injections 2x/month. Outcome is injections and monitoring for life. 2. Burst Appendix 2 years after Covid 19 Modern with mucin in abdomen. Treatment is HPEC surgery was recommended but refused; MRI, CT, blood tests for tumor markers, MRI again, monitoring for life.
More
|
โ | โ | ||||
| 2828513 | 18 | M | CA | 02/26/2025 |
COVID19 |
MODERNA |
|
Lymphadenitis, Lymphadenopathy, SARS-CoV-2 test negative
Lymphadenitis, Lymphadenopathy, SARS-CoV-2 test negative
|
Enlarged/inflamed lymph nodes, persist today, years later. Never had a positive covid test even thou...
Enlarged/inflamed lymph nodes, persist today, years later. Never had a positive covid test even though I took them whenever me or someone in my family was symptomatic. My reason for including this is: it seems to me to be from the vaccine not ?long covid? or anything other than the vaccine.
More
|
โ | |||||
| 2828514 | 26 | F | KS | 02/26/2025 |
COVID19 |
MODERNA |
|
Caesarean section, Exposure during pregnancy, Foetal hypokinesia, Foetal monitor...
Caesarean section, Exposure during pregnancy, Foetal hypokinesia, Foetal monitoring
More
|
Received first dose of moderna covid vaccine from pharmacy while 36 weeks pregnant. No side effects ...
Received first dose of moderna covid vaccine from pharmacy while 36 weeks pregnant. No side effects other than a sore arm. Received the second dose of moderna covid vaccine from pharmacy at 38 weeks pregnant, after/at 5 pm on 10/21/21. That evening, I Noticed the fetus/ infant stopped moving. Admitted to labor and delivery triage the next morning to monitor fetal vitals. Due to decreased fetal movement, the infant was delivered via emergency c-section on the same day, 10/xx/24. The original delivery date was 11/1/2021. Baby was considered full term at 38 weeks, weighing 6 lbs 2 oz.
More
|
โ | |||||
| 2827940 | F | TX | 02/25/2025 |
HPV4 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. |
|
Vulval cancer; Vulval cancer
Vulval cancer; Vulval cancer
|
the HCP believes she is in the "initial stages of vulvar cancer; the patient has had problems; ...
the HCP believes she is in the "initial stages of vulvar cancer; the patient has had problems; This spontaneous report was received from a physician via company representative and refers to a 34-year-old female patient. The patient's medical history included vulvectomy, sexual debut in 2005, and had a child in 2008. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unspecified date in 2009, the patient completed the vaccine series with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) (strength, dose, frequency, lot #, and expiration date were not reported) or Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL) (strength, dose, frequency, lot #, and expiration date were not reported) for prophylaxis (reporter stated she believed, however was unable to confirm which vaccine the patient received). Since 2016, the patient had had problems. No additional details were provided regarding those problems. The patient was seen on 13-FEB-2025, the healthcare provided (HCP) believed she was in the "initial stages of vulvar cancer." No additional details provided. At the reporting time, the outcome of the events was unknown. The causal relationship between the events, Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9), and Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL) was unknown. Lot # is being requested and will be submitted if received. Upon internal review, the event of vulvar cancer was determined to be medically significant.
More
|
|||||||
| 2827941 | 69 | M | NJ | 02/25/2025 |
VARZOS VARZOS VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
|
Rash pruritic, Rash vesicular; Rash, Rash pruritic; Rash pruritic, Rash vesicula...
Rash pruritic, Rash vesicular; Rash, Rash pruritic; Rash pruritic, Rash vesicular; Rash, Rash pruritic
More
|
itchy rash like chicken pox or mosquito bites; This non-serious case was reported by a consumer via ...
itchy rash like chicken pox or mosquito bites; This non-serious case was reported by a consumer via call center representative and described the occurrence of varicella-like rash in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included COVID-19 vaccine and Influenza vaccine (Flu vaccine VII). On 20-JAN-2025, the patient received the 1st dose of Shingrix (intramuscular, left arm). In JAN-2025, 24 hrs after receiving Shingrix, the patient experienced varicella-like rash (Verbatim: itchy rash like chicken pox or mosquito bites). The outcome of the varicella-like rash was resolving. It was unknown if the reporter considered the varicella-like rash to be related to Shingrix. It was unknown if the company considered the varicella-like rash to be related to Shingrix. Additional Information: GSK Receipt Date: 27-JAN-2025 The patient received his first dose of Shingrix in his left arm on 20-JAN-2025, and reported that 24 hours after receiving the vaccine, he got a very itchy rash like chicken pox or mosquito bites, in one area of his lower back, just at the top of his touche. The patient reported that rash was much less itchy on 27-JAN-2025 and was almost gone. The patient did not have any lot, expiry, NDC information to provide. The patient reported that he received a Covid vaccine and a high dose Flu vaccine about 3 or 4 weeks ago (Unknown Products Information) (Pre existing Shingrix).
More
|
||||||
| 2827942 | M | FL | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
|
Seizure, Viral infection
Seizure, Viral infection
|
seizures; This spontaneous serious safety report with reference number 02742982 (Interaction number ...
seizures; This spontaneous serious safety report with reference number 02742982 (Interaction number 02742981) was received by a partner on 27-JAN-2025 and forwarded on 28-JAN-2025 from a health care professional. A 6-month-old male patient had been vaccinated with unknown dose of Vaxelis (batch number not provided), on an unknown date for prophylaxis. No medical history was provided. No concomitant vaccinations were reported. On an unknown date, the patient experienced seizures after recently having been administered a dose of Vaxelis. The provider reported that the infant was hospitalized, and it was determined that he had a virus. She also stated that the infant recovered and went on to receive additional immunizations. The event was recovered/resolved. Action taken with Vaxelis was unknown. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event of "seizures". It was reported that the patient had a virus (alternative causality). Further information is expected. COMPANY COMMENT: Seizure is assessed as serious due to causing hospitalization. Seizure is listed for Vaxelis as per the Reference Safety Information. Considering the current knowledge on Vaxelis (Seizure is listed as per regulatory authority) and that the events appeared after the recent vaccination with Vaxelis, and despite the lack of information (relevant medical history not provided) and no confounding factors (co-suspect vaccines), and the alternate causality (virus positive) provided, the causal relationship between Vaxelis and Seizure cannot be excluded and is assessed as related. This single individual case safety report does not modify the benefit/risk balance of this product. Therefore, no change in the label or other measures is recommended at this time. However, the company will continue to monitor all respective reports received and based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.; Sender's Comments: Seizure is assessed as serious due to causing hospitalization. Seizure is listed for Vaxelis as per the Reference Safety Information. Considering the current knowledge on Vaxelis (Seizure is listed as per regulatory authority) and that the events appeared after the recent vaccination with Vaxelis, and despite the lack of information (relevant medical history not provided) and no confounding factors (co-suspect vaccines), and the alternate causality (virus positive) provided, the causal relationship between Vaxelis and Seizure cannot be excluded and is assessed as related. This single individual case safety report does not modify the benefit/risk balance of this product. Therefore, no change in the label or other measures is recommended at this time. However, the company will continue to monitor all respective reports received and based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.
More
|
โ | ||||||
| 2827943 | MO | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
U7907AA |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
a dose of VAXELIS was given to a 5 year old patient.; This non-serious spontaneous safety report wit...
a dose of VAXELIS was given to a 5 year old patient.; This non-serious spontaneous safety report with reference number: 02729137 (interaction number: 02729135 ) was received by MSD, on 03-JAN-2025 and forwarded to agency on 03-JAN-2025 from a medical assistant. Due to the nature of the event, the causality between the event "a dose of VAXELIS was given to a 5 year old patient" and Vaxelis was not applicable. Case was considered as off-label use due to the reported event of patient being administered Vaxelis at age of 5 years. No further information is expected.
More
|
||||||||
| 2827944 | F | TX | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
u792188 |
Product storage error
Product storage error
|
HCP called to report TE where ROTATEQ, VAXELIS and VAXNEUVANCE were administered to one patient.; Th...
HCP called to report TE where ROTATEQ, VAXELIS and VAXNEUVANCE were administered to one patient.; This non-serious spontaneous safety report, with reference number 02731387 (interaction number: 02731358), was received by partner on 07-JAN-2025 and forwarded to UBC on 08-JAN-2025 from other health professional. Due to the nature of the event, the causality between the event 'HCP called to report TE where ROTATEQ, VAXELIS and VAXNEUVANCE were administered to one patient' and Vaxelis was not applicable. Further information is expected.
More
|
|||||||
| 2827945 | F | LA | 02/25/2025 |
DTPPVHBHPB VARCEL |
MSP VACCINE COMPANY MERCK & CO. INC. |
U7921AA |
Extra dose administered; Extra dose administered
Extra dose administered; Extra dose administered
|
Extra dose administered; an inappropriate use due to medical assistant inadvertently administered VA...
Extra dose administered; an inappropriate use due to medical assistant inadvertently administered VAXELIS instead of Varivax; This non-serious spontaneous safety report, with reference number 2025SA011036, was received by partner on 10-JAN-2025 and forwarded to UBC on 13-JAN-2025 from the physician. Due to the nature of the event, the causality between the events 'an inappropriate use due to medical assistant inadvertently administered VAXELIS instead of Varivax, Extra dose administered' and Vaxelis was not applicable. Further information is expected. Significant follow-up was received by partner on 24-JAN-2025 and forwarded to UBC on 24-JAN-2025 from the physician in the United States. The case remained as non-serious, with concomitant vaccinations provided. Due to the nature of the event, the causality between the events 'an inappropriate use due to medical assistant inadvertently administered VAXELIS instead of Varivax, Extra dose administered' and Vaxelis was not applicable. Further information is not expected.
More
|
|||||||
| 2827946 | CA | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
|
Inflammation, Lymphadenitis, Malaise, Pyrexia
Inflammation, Lymphadenitis, Malaise, Pyrexia
|
malaise; Lymphadatitis; high inflammation; high fever; This non-serious spontaneous safety report, w...
malaise; Lymphadatitis; high inflammation; high fever; This non-serious spontaneous safety report, with reference number 02733834 (interaction number: 02733830), was received by partner on 10-JAN-2025 and forwarded to UBC on 13-JAN-2025 from physician. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events, 'high fever, malaise, lymphadenitis, and high inflammation'. Further information is not expected. Non-significant follow-up information was received via email on 27-JAN-2025, from a physician. The case is maintained as non-serious. Further information is not expected.
More
|
||||||||
| 2827947 | CA | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
|
Inflammation, Lymphadenitis, Malaise, Pyrexia
Inflammation, Lymphadenitis, Malaise, Pyrexia
|
Malaise; Lymphadenitis; High inflammation; High fever; This non-serious spontaneous safety report, w...
Malaise; Lymphadenitis; High inflammation; High fever; This non-serious spontaneous safety report, with reference number 02733835 (interaction number: 02733830), was received by partner on 10-JAN-2025 and forwarded to UBC on 13-JAN-2025 from physician. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events, 'high fever, malaise, lymphadatitis, and high inflammation'. Further information is expected.
More
|
||||||||
| 2827948 | M | CO | 02/25/2025 |
DTAP DTAPIPVHIB DTPPVHBHPB HIBV IPV MMR |
SANOFI PASTEUR SANOFI PASTEUR MSP VACCINE COMPANY SANOFI PASTEUR SANOFI PASTEUR UNKNOWN MANUFACTURER |
|
Extra dose administered; Extra dose administered; Extra dose administered; Extra...
Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered
More
|
it was supposed to be PENTACEL to be administered, the assistant who administered the vaccines got c...
it was supposed to be PENTACEL to be administered, the assistant who administered the vaccines got confused whether to inject VAXELIS or PENTACEL; Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and 16-JAN-2025; Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and Pentacel; This non-serious spontaneous safety report was received by partner on 14-JAN-2025 and forwarded to UBC on 16-JAN-2025 from a healthcare professional. Due to the nature of the event, the causality assessment between Vaxelis and the events were not applicable. Further information is expected. Non-significant follow-up information was received by the partner on 27-JAN-2025 and forwarded to UBC on 29-JAN-2025, from other health professional. The case is maintained as non-serious. Due to the nature of the event, the causality between the event "it was supposed to be PENTACEL to be administered, the assistant who administered the vaccines got confused whether to inject VAXELIS or PENTACEL", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and 16-JAN-2025", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and Pentacel" and Vaxelis was not applicable. Further information is not expected. Significant follow-up information was received by the partner on 27-JAN-2025 and forwarded to UBC on 28-JAN-2025, from other health professional. The case is maintained as non-serious. Due to the nature of the event, the causality between the event "it was supposed to be PENTACEL to be administered, the assistant who administered the vaccines got confused whether to inject VAXELIS or PENTACEL", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and 16-JAN-2025", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and Pentacel" and Vaxelis was not applicable. Further information is not expected. Significant follow-up information was received by the partner on 30-JAN-2025 and forwarded to UBC on 30-JAN-2025, from other health professional. The case is maintained as non-serious. Due to the nature of the event, the causality between the event "it was supposed to be PENTACEL to be administered, the assistant who administered the vaccines got confused whether to inject VAXELIS or PENTACEL", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and 16-JAN-2025", "Patient received an extra dose of DTaP-IPV-Hib components from the VAXELIS and Pentacel" and Vaxelis was not applicable. Further information is not expected.
More
|
|||||||
| 2827949 | UT | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
|
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
Child received a dose of VAXELIS at 2 months old and another dose at 4 months old. At 6 months old t...
Child received a dose of VAXELIS at 2 months old and another dose at 4 months old. At 6 months old the child received the PEDIARIX vaccine; This non-serious spontaneous safety report, with reference number 02737956 (interaction number: 02737889), was received by the partner on 17-JAN-2025 and forwarded to UBC on 17-JAN-2025, from other health professional. Due to the nature of the event, the causality between the event "Child received a dose of VAXELIS at 2 months old and another dose at 4 months old. At 6 months old the child received the PEDIARIX vaccine" and Vaxelis was not applicable. Further information is expected.
More
|
||||||||
| 2827950 | F | FL | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
U7295AA |
Product administered to patient of inappropriate age, Product preparation error
Product administered to patient of inappropriate age, Product preparation error
|
an inappropriate use due to VAXELIS inadvertently given to a patient instead of a Flu Shot; 9-year-o...
an inappropriate use due to VAXELIS inadvertently given to a patient instead of a Flu Shot; 9-year-old patient; This non-serious spontaneous, safety report was received by partner, on 31-JAN-2025 and forwarded to UBC on 03-FEB-2025 from a healthcare professional. This case is considered off-label use, due to product use in unapproved population, as the patient is 9 years old. The reporter did not provide an assessment of the causal relationship between Vaxelis and "an inappropriate use due to VAXELIS inadvertently given to a patient instead of a Flu Shot". Further information is expected.
More
|
|||||||
| 2827951 | M | CO | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
U7899AA |
Wrong product administered
Wrong product administered
|
Friday vaccinated 15-month old VAXELIS instead of DAPTACEL Inquiry Comments:; This non-serious spont...
Friday vaccinated 15-month old VAXELIS instead of DAPTACEL Inquiry Comments:; This non-serious spontaneous safety report, with reference number 2025SA034914, was received by partner on 03-FEB-2025 and forwarded to UBC on 04-FEB-2025 from other health professional. Due to the nature of the event, the causality between the event 'Friday vaccinated 15-month old VAXELIS instead of DAPTACEL' and Vaxelis was not applicable. Further information is expected.
More
|
|||||||
| 2827952 | F | CO | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
|
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
Patient received an early dose of VAXELIS and is wondering about potential side effects; This non-se...
Patient received an early dose of VAXELIS and is wondering about potential side effects; This non-serious spontaneous safety report, with reference number 2025SA036455, was received by partner on 04-FEB-2025 and forwarded to UBC on 05-FEB-2025 from other health professional. Off-label classification was added due to an early dose of Vaxelis being administered (inappropriate schedule of vaccine). Due to the nature of the event, the causality between the events 'Patient received an early dose of VAXELIS and is wondering about potential side effects' and Vaxelis was not applicable. Further information is expected.
More
|
|||||||
| 2827953 | F | WV | 02/25/2025 |
DTPPVHBHPB FLU3 |
MSP VACCINE COMPANY SANOFI PASTEUR |
UT8419CA |
Wrong product administered; Wrong product administered
Wrong product administered; Wrong product administered
|
Was supposed to get VAXELIS but she was administered FLUZONE (pf) instead.; This non-serious spontan...
Was supposed to get VAXELIS but she was administered FLUZONE (pf) instead.; This non-serious spontaneous safety report, with reference number 2025SA039561, was received by partner on 07-FEB-2025 and forwarded to agency on 10-FEB-2025 from other health professional. Due to the nature of the event, the causality between the events 'was suppose to get VAXELIS but she was administered FLUZONE (pf) instead' and Vaxelis was not applicable. Further information is not expected.
More
|
|||||||
| 2827954 | M | CA | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
U7947AA |
Extra dose administered
Extra dose administered
|
administration of VAXELIS instead of Quadracel; patient receiving extra doses of Hib and hepatitis ...
administration of VAXELIS instead of Quadracel; patient receiving extra doses of Hib and hepatitis B antigens.; This non-serious spontaneous safety report, with reference number 2025SA043502 (Inquiry number 02407940), was received by partner on 10-FEB-2025 and forwarded to UBC on 12-FEB-2025 from other health professional. Due to the nature of the events, the causality between the events 'administration of VAXELIS instead of Quadracel' and 'patient receiving extra doses of Hib and hepatitis B antigens.' and Vaxelis was not applicable. Further information is expected.
More
|
|||||||
| 2827955 | F | IL | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
u7921aa |
Syringe issue, Underdose
Syringe issue, Underdose
|
Patient didn't receive a complete dose of vaccine.; HCP stated that while administering injecti...
Patient didn't receive a complete dose of vaccine.; HCP stated that while administering injection to patient, contents of syringe 'sprayed out everywhere' between luer lock and needle attachment.; This non-serious spontaneous safety report, with reference number 02751876 (interaction number: 02751871), was received by partner on 11-FEB-2025 and forwarded to UBC on 11-FEB-2025 from other health professional. Additional information was received by partner on 12-FEB-2025 and forwarded to UBC on 13-FEB-2025 from other health professional. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events, 'Patient didn't receive a complete dose of vaccine' and 'HCP stated that while administering injection to patient, contents of syringe 'sprayed out everywhere' between luer lock and needle attachment'. Further information is expected.
More
|
|||||||
| 2827956 | M | UT | 02/25/2025 |
DTPPVHBHPB HEP |
MSP VACCINE COMPANY MERCK & CO. INC. |
U7899AA X027728 |
Extra dose administered; Extra dose administered
Extra dose administered; Extra dose administered
|
administered both the RECOMBIVAX HB and VAXELIS Vaccines on the same day; inadvertently administered...
administered both the RECOMBIVAX HB and VAXELIS Vaccines on the same day; inadvertently administered both the RECOMBIVAX HB and VAXELIS Vaccines on the same day; This serious spontaneous safety report with MSD reference number #02752914was received by the partner on 12-FEB-2025 and forwarded to UBC on 13-FEB-2025, from a healthcare professional. Due to the nature of the event, the causal relationship between Vaxelis and the reported event of "administered both the RECOMBIVAX HB and VAXELIS Vaccines on the same day" was not applicable. Further information is expected.
More
|
|||||||
| 2827957 | SC | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
U7767AA |
Extra dose administered
Extra dose administered
|
patient inadvertently received 2 vaccinations of VAXELIS in the same visit.; This serious spontaneou...
patient inadvertently received 2 vaccinations of VAXELIS in the same visit.; This serious spontaneous safety report with MSD reference number #002754092 was received by the partner on 14-FEB-2025 and forwarded to UBC on 14-FEB-2025, from a healthcare professional. Due to the nature of the event, the causal relationship between Vaxelis and the reported event of "patient inadvertently received 2 vaccinations of VAXELIS in the same visit" was not applicable. Further information is expected.
More
|
||||||||
| 2827969 | 54 | F | WA | 02/25/2025 |
COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH |
EL0140 EL1283 |
Biopsy lymph gland, Diffuse large B-cell lymphoma; Biopsy lymph gland, Diffuse l...
Biopsy lymph gland, Diffuse large B-cell lymphoma; Biopsy lymph gland, Diffuse large B-cell lymphoma
More
|
Diffuse Large B cell lymphoma
Diffuse Large B cell lymphoma
|
โ | |||||
| 2827970 | 53 | F | ID | 02/25/2025 |
COVID19 COVID19 COVID19 |
MODERNA MODERNA MODERNA |
037K20A 037K20A 037K20A |
Anti-cyclic citrullinated peptide antibody, Antinuclear antibody, Blood immunogl...
Anti-cyclic citrullinated peptide antibody, Antinuclear antibody, Blood immunoglobulin A, Blood immunoglobulin G, Blood uric acid; C-reactive protein, Complement factor C3, Complement factor C4, Double stranded DNA antibody, HLA marker study; Immunology test, Postmenopausal haemorrhage, Red blood cell sedimentation rate, Rheumatoid arthritis, Rheumatoid factor
More
|
after receiving my COVID vaccine series 2 events happened. One I had vaginal bleeding for 6 weeks, ...
after receiving my COVID vaccine series 2 events happened. One I had vaginal bleeding for 6 weeks, post menopausal. The second is that in 2023 I developed Rheumatoid Arthritis. I do not know if there is a link but I think it should be reported. Thanks.
More
|
||||||
| 2827980 | 78 | F | LA | 02/25/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Injection site erythema, Injection site pain, Injection site pruritus
Injection site erythema, Injection site pain, Injection site pruritus
|
redness right deltoid injection site; itching right deltoid injection site; soreness right deltoid i...
redness right deltoid injection site; itching right deltoid injection site; soreness right deltoid injection site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 78-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On 06-FEB-2025, the patient received Arexvy .5 ml. On 06-FEB-2025, less than a day after receiving Arexvy, the patient experienced injection site erythema (Verbatim: redness right deltoid injection site), injection site itching (Verbatim: itching right deltoid injection site) and injection site muscle pain (Verbatim: soreness right deltoid injection site). The outcome of the injection site erythema, injection site itching and injection site muscle pain were not resolved. It was unknown if the reporter considered the injection site erythema, injection site itching and injection site muscle pain to be related to Arexvy. It was unknown if the company considered the injection site erythema, injection site itching and injection site muscle pain to be related to Arexvy. Additional Information: GSK Receipt Date: 14-FEB-2025 The reporter reported there was no other conditions provided. Pharmacy did not provide lot number.
More
|
||||||
| 2827981 | M | FL | 02/25/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Incomplete course of vaccination
Incomplete course of vaccination
|
First Vaccination - Missed Second; This non-serious case was reported by a consumer via call center ...
First Vaccination - Missed Second; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (on 09-JUL-2024 received 1st dose). On an unknown date, the patient did not receive Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incomplete course of vaccination (Verbatim: First Vaccination - Missed Second). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 17-FEB-2025 The patient received 1st dose of Shingles vaccine. Till the time of reporting the patient had not received the second dose of Shingles vaccine, which led to incomplete course of vaccination.
More
|
|||||||
| 2827983 | F | 02/25/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Nausea
Nausea
|
Nausea; This non-serious case was reported by a consumer and described the occurrence of nausea in a...
Nausea; This non-serious case was reported by a consumer and described the occurrence of nausea in a 55-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concomitant products included fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (Trelegy). On 21-FEB-2025, the patient received Shingles vaccine. On 23-FEB-2025, 2 days after receiving Shingles vaccine, the patient experienced nausea (Verbatim: Nausea). The outcome of the nausea was not resolved. It was unknown if the reporter considered the nausea to be related to Shingles vaccine. It was unknown if the company considered the nausea to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 23-FEB-2025 The patient self-reported this case The patient received Shingles vaccine and experienced nausea and was not treated
More
|
||||||||
| 2827984 | 02/25/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Influenza like illness
Influenza like illness
|
flu-like symptoms; This non-serious case was reported by a consumer and described the occurrence of ...
flu-like symptoms; This non-serious case was reported by a consumer and described the occurrence of influenza-like symptoms in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: flu-like symptoms). The outcome of the influenza-like symptoms was resolved. It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix. It was unknown if the company considered the influenza-like symptoms to be related to Shingrix. Additional Information: GSK Receipt Date: 21-FEB-2025 The reporter reported that patient received the Shingrix vaccine and had flu-like symptoms for couple of days. The other was Zostavax but it was supposed to be discontinued.
More
|